Cargando…
CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176024/ https://www.ncbi.nlm.nih.gov/pubmed/35847745 http://dx.doi.org/10.1002/jha2.63 |
| _version_ | 1784722573313966080 |
|---|---|
| author | Messori, Andrea |
| author_facet | Messori, Andrea |
| author_sort | Messori, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9176024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91760242022-07-14 CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma Messori, Andrea EJHaem Letters John Wiley and Sons Inc. 2020-07-13 /pmc/articles/PMC9176024/ /pubmed/35847745 http://dx.doi.org/10.1002/jha2.63 Text en © 2020 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters Messori, Andrea CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title | CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title_full | CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title_fullStr | CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title_full_unstemmed | CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title_short | CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| title_sort | car‐t treatment: determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176024/ https://www.ncbi.nlm.nih.gov/pubmed/35847745 http://dx.doi.org/10.1002/jha2.63 |
| work_keys_str_mv | AT messoriandrea carttreatmentdeterminingtheprogressionfreesurvivalgaininpatientswithheavilypretreatedmultiplemyeloma |